Avecho Biotechnology Limited (AVEFF)

USD 0.0

(157.14%)

Long Term Debt Summary of Avecho Biotechnology Limited

  • Avecho Biotechnology Limited's latest annual long term debt in 2023 was 98.22 Thousand AUD , down -43.92% from previous year.
  • Avecho Biotechnology Limited's latest quarterly long term debt in 2024 Q2 was - AUD , down 0.0% from previous quarter.
  • Avecho Biotechnology Limited reported annual long term debt of 175.15 Thousand AUD in 2022, up 1178.2% from previous year.
  • Avecho Biotechnology Limited reported annual long term debt of 13.7 Thousand AUD in 2021, down -85.3% from previous year.
  • Avecho Biotechnology Limited reported quarterly long term debt of - AUD for 2024 Q2, down 0.0% from previous quarter.
  • Avecho Biotechnology Limited reported quarterly long term debt of 98.22 Thousand AUD for 2023 Q3, down -28.52% from previous quarter.

Annual Long Term Debt Chart of Avecho Biotechnology Limited (2023 - 1993)

Historical Annual Long Term Debt of Avecho Biotechnology Limited (2023 - 1993)

Year Long Term Debt Long Term Debt Growth
2023 98.22 Thousand AUD -43.92%
2022 175.15 Thousand AUD 1178.2%
2021 13.7 Thousand AUD -85.3%
2020 93.2 Thousand AUD 1111.02%
2019 7696.00 AUD 0.0%
2018 - AUD 0.0%
2017 - AUD 0.0%
2016 - AUD 0.0%
2015 - AUD 0.0%
2014 - AUD 0.0%
2013 - AUD 0.0%
2012 - AUD 0.0%
2011 - AUD 0.0%
2010 - AUD 0.0%
2009 - AUD 0.0%
2008 - AUD 0.0%
2007 - AUD 0.0%
2006 - AUD 0.0%
2005 - AUD 0.0%
2004 - AUD 0.0%
2003 - AUD 0.0%
2002 - AUD 0.0%
2001 - AUD 0.0%
2000 - AUD 0.0%
1999 - AUD 0.0%
1998 - AUD 0.0%
1997 - AUD 0.0%
1996 - AUD 0.0%
1995 - AUD 0.0%
1994 - AUD 0.0%
1993 - AUD 0.0%

Peer Long Term Debt Comparison of Avecho Biotechnology Limited

Name Long Term Debt Long Term Debt Difference
ContraFect Corporation 2.21 Million USD 95.555%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Ember Therapeutics, Inc. - USD -Infinity%
THC Farmaceuticals, Inc. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 57.236%
Zenith Capital Corp. 4456.00 USD -2104.331%
GlobeStar Therapeutics Corporation - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Oncotelic Therapeutics, Inc. 1.89 Million USD 94.826%
Institute of Biomedical Research Corp. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 92.999%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 94.405%
Propanc Biopharma, Inc. 58.64 Thousand USD -67.499%
Qrons Inc. 80 Thousand USD -22.781%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD 22.23%
Accustem Sciences Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
EV Biologics, Inc. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 82.289%
Arch Therapeutics, Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 98.19%
Burzynski Research Institute, Inc. - USD -Infinity%
Biomind Labs Inc. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 98.811%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 92.004%
CytoDyn Inc. 141 Thousand USD 30.337%
Evofem Biosciences, Inc. 8000.00 USD -1127.813%
IMV Inc. 27.39 Million USD 99.641%
Genus plc 228.2 Million USD 99.957%
Halberd Corporation 150 Thousand USD 34.517%
Helix BioMedix, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
LadRx Corporation - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD 85.276%
NanoSphere Health Sciences Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 95.587%
PsyBio Therapeutics Corp. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 34.348%
Enzolytics Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.999%
Skye Bioscience, Inc. 171.23 Thousand USD 42.636%
SQZ Biotechnologies Company 20.9 Million USD 99.53%
Therapeutic Solutions International, Inc. 5512.00 USD -1682.021%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 57.161%
Endonovo Therapeutics, Inc. - USD -Infinity%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Nymox Pharmaceutical Corporation - USD -Infinity%
NovAccess Global Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD 67.258%
RVL Pharmaceuticals plc 55.61 Million USD 99.823%
Alpha Cognition Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Mesoblast Limited 100.29 Million USD 99.902%
MultiCell Technologies, Inc. 36.43 USD -269526.681%
Intellipharmaceutics International Inc. - USD -Infinity%
Acro Biomedical Co., Ltd. - USD -Infinity%
Neon Bloom, Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.941%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 69.495%
argenx SE 15.35 Million USD 99.36%
Resverlogix Corp. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
Nuo Therapeutics, Inc. 164.2 Thousand USD 40.181%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 99.516%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -288.256%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
ONE Bio Corp. 592.19 Thousand USD 83.413%
Genscript Biotech Corporation 287.12 Million USD 99.966%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
Adynxx, Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD 63.023%
Oncology Pharma Inc. - USD -Infinity%
Reve Technologies, Inc. 1064.00 USD -9131.673%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD 34.348%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 98.744%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 73.384%
Mobile Lads Corp. - USD -Infinity%
International Stem Cell Corporation 445 Thousand USD 77.927%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 98.795%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 78.507%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 91.54%
PureTech Health plc 18.25 Million USD 99.462%
Coeptis Therapeutics, Inc. 150 Thousand USD 34.517%
IXICO plc 275 Thousand USD 64.282%
IntelGenx Technologies Corp. 11.83 Million USD 99.17%
Gelesis Holdings, Inc. 26.3 Million USD 99.627%
CSL Limited 11.23 Billion USD 99.999%
Cellectis S.A. 36.21 Million USD 99.729%